Arachidonic acid-induced gene expression in colon cancer cells.

It is well documented that arachidonic acid (AA) and its metabolites are intimately linked to cancer biology. However, the downstream mechanism(s) that link AA levels to cancer cell proliferation remain to be elucidated. Initial experiments in the current study showed that exogenous AA and inhibitors of AA metabolism that lead to the accumulation of unesterified AA are cytotoxic to the colon cancer cell line, HCT-116. Additionally, exogenous AA and triacsin C, an inhibitor of AA acylation, induced apoptosis and related caspase-3 activity in a transcriptionally dependent manner. Gene array analysis revealed that both exogenous AA and triacsin C alter the expression of similar genes in HCT-116 cells. For example, both downregulate several genes with well-documented roles in cell survival and apoptotic resistance. Conversely, both upregulate genes encoding activator protein-1 (AP-1) transcription factors, which have known roles in inducing apoptosis, and genes that counteract ras (Erk/MAPK) growth signaling pathways. Real-time polymerase chain reaction and immunoblotting demonstrated that mRNA and protein levels of one of the major AP-1 transcription factors, c-Jun, is markedly elevated by exogenous AA and triacsin C. Additionally, the cyclooxygenase inhibitor, sulindac sulfide, increases c-Jun mRNA levels. Together, these studies reveal that the generation of intracellular AA and its subsequent impact on gene expression probably represents a critical step that regulates colon cancer cell proliferation.

[1]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[2]  D. Bostwick,et al.  Lipoxygenase‐5 is overexpressed in prostate adenocarcinoma , 2001, Cancer.

[3]  Fan Zhang,et al.  Cyclooxygenase-2 is overexpressed in human cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[5]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[6]  J. Baraban,et al.  A Dominant Negative Inhibitor of the Egr Family of Transcription Regulatory Factors Suppresses Cerebellar Granule Cell Apoptosis by Blocking c-Jun Activation , 2001, The Journal of Neuroscience.

[7]  S. Prescott,et al.  Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer , 2002, Journal of cellular physiology.

[8]  H. S. Kim,et al.  Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  S. Bates,et al.  Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. , 1996, Cancer research.

[10]  B. Wong,et al.  12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. , 2001, Carcinogenesis.

[11]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[12]  F. Chilton,et al.  Antineoplastic properties of arachidonic acid and its metabolites. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  A. Wittinghofer,et al.  Characterisation of PDZ-GEFs, a family of guanine nucleotide exchange factors specific for Rap1 and Rap2. , 2003, Biochimica et biophysica acta.

[14]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[15]  J. Baraban,et al.  A Dominant Negative Egr Inhibitor Blocks Nerve Growth Factor-Induced Neurite Outgrowth by Suppressing c-Jun Activation: Role of an Egr/c-Jun Complex , 2002, The Journal of Neuroscience.

[16]  D. Grignon,et al.  Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. , 1995, Urology.

[17]  K. Matsumoto,et al.  Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. , 1995, Cancer research.

[18]  Y. Shyr,et al.  Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. , 2000, The American journal of pathology.

[19]  E. Liu,et al.  Topoisomerase IIα gene (TOP2A) amplification and deletion in cancer – more common than anticipated , 2003, Cytopathology : official journal of the British Society for Clinical Cytology.

[20]  P. Stern,et al.  Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours , 2001, Oncogene.

[21]  C. Koumenis,et al.  Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  S. Prescott,et al.  Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. , 2001, Cancer research.

[23]  E. Tibaldi,et al.  Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. , 2003, Biochemistry.

[24]  G. Gores,et al.  Increased expression of cyclooxygenase‐2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors , 2002, Cancer.

[25]  R. DuBois,et al.  Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. , 1996, Gastroenterology clinics of North America.

[26]  K. Umehara,et al.  CROP/Luc7A, a novel serine/arginine‐rich nuclear protein, isolated from cisplatin‐resistant cell line1 , 2000, FEBS letters.

[27]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[28]  R. Morimoto,et al.  Arachidonate is a potent modulator of human heat shock gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Bos,et al.  Ras and Rap1: two highly related small GTPases with distinct function. , 1999, Experimental cell research.

[30]  H. Verspaget,et al.  Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs. , 2000, Scandinavian Journal of Gastroenterology, Supplement.

[31]  M. Vail,et al.  Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis , 2002, Oncogene.

[32]  D. Chopin,et al.  Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas , 1999, Nature Genetics.

[33]  J. Masferrer,et al.  COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.

[34]  O. Pignataro,et al.  Interaction between arachidonic acid and cAMP signaling pathways enhances steroidogenesis and StAR gene expression in MA-10 Leydig tumor cells , 2002, Molecular and Cellular Endocrinology.

[35]  C. Giardina,et al.  Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon Tumorigenesis , 2005, Clinical Cancer Research.

[36]  Michele Pagano,et al.  Deregulated degradation of the cdk inhibitor p27 and malignant transformation. , 2003, Seminars in cancer biology.

[37]  G. Zimmerman,et al.  Intracellular unesterified arachidonic acid signals apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. L. Bergsagel,et al.  The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells. , 2001, Blood.

[39]  A. Fonteh,et al.  A Decrease in Remodeling Accounts for the Accumulation of Arachidonic Acid in Murine Mast Cells Undergoing Apoptosis* , 2001, The Journal of Biological Chemistry.

[40]  Y. Chen,et al.  Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. , 2001, Carcinogenesis.

[41]  K. Kashfi,et al.  Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. , 2005, Biochemical pharmacology.

[42]  M. Chou,et al.  Dentin bonding agents induce c-fos and c-jun protooncogenes expression in human gingival fibroblasts. , 2003, Biomaterials.

[43]  S. Di Giovanni,et al.  BOK and NOXA Are Essential Mediators of p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[44]  A. Grothey,et al.  Cyclooxygenase-2: a novel target for cancer chemotherapy? , 2001, Journal of Cancer Research and Clinical Oncology.

[45]  J Vandekerckhove,et al.  Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. , 1993, Experimental cell research.

[46]  M. Hagiwara,et al.  Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A. , 2003, Biochemical and biophysical research communications.

[47]  F. Chilton,et al.  Arachidonate-phospholipid remodeling and cell proliferation. , 1996, Advances in experimental medicine and biology.

[48]  Y. Bignon,et al.  Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines , 2002, British Journal of Nutrition.

[49]  F. Marks,et al.  A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. , 2000, Toxicology.

[50]  R. Morimoto,et al.  The transcriptional regulation of heat shock genes: a plethora of heat shock factors and regulatory conditions. , 1996, EXS.

[51]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[52]  E. Giovannucci.  The prevention of colorectal cancer by aspirin use. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[53]  Dena Leshkowitz,et al.  Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis , 2002, Molecular and Cellular Biology.

[54]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[55]  C. Walsh,et al.  Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Michael B Yaffe,et al.  14-3-3 Proteins--a focus on cancer and human disease. , 2004, Journal of molecular and cellular cardiology.

[57]  T. Hiwasa,et al.  Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma , 2004, Cancer.

[58]  J. Ribalta,et al.  Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages. , 2002, Atherosclerosis.

[59]  S. Trudel,et al.  Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance. , 2002, Blood.

[60]  H. Boswell,et al.  Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-alpha: evidence for a tyrosine-kinase-dependent process. , 1995, Blood.

[61]  A. Fonteh,et al.  Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. , 2000, The Journal of nutrition.

[62]  A. Weeraratna,et al.  Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. , 2000, Cancer research.

[63]  J. Jaboin,et al.  Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. , 2002, Cancer research.

[64]  A. Fonteh,et al.  Relationship between arachidonate--phospholipid remodeling and apoptosis. , 1996, Biochemistry.

[65]  A. Watson,et al.  Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. , 1998, Histology and histopathology.

[66]  W. Lands,et al.  Stories about acyl chains. , 2000, Biochimica et biophysica acta.

[67]  Y. Oh.  IGFBPs and neoplastic models , 1997, Endocrine.

[68]  R. Mayer,et al.  Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils. , 1995, Biochemistry.

[69]  R. Mayer,et al.  Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[70]  Michael F. Olson,et al.  RAS and RHO GTPases in G1-phase cell-cycle regulation , 2004, Nature Reviews Molecular Cell Biology.

[71]  M. Rizzo,et al.  Arachidonic acid induces mobilization of calcium stores and c-jun gene expression: evidence that intracellular calcium release is associated with c-jun activation. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[72]  Qiang Liu,et al.  Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. , 2003, Carcinogenesis.

[73]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[74]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[75]  U. Danesch,et al.  Modulation of the expression of early genes by polyunsaturated fatty acids. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[76]  M. Willingham,et al.  Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells. , 1999, Cancer research.

[77]  L. Razanamahefa,et al.  Stimulatory Effect of Arachidonic Acid on T-47DHuman Breast Cancer Cell Growth Is Associated WithEnhancement of Cyclin D1 mRNA Expression , 2000, Nutrition and cancer.

[78]  K. Kinzler,et al.  Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Triggiani,et al.  Control of arachidonate levels within inflammatory cells. , 1996, Biochimica et biophysica acta.